Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-23-000032
Filing Date
2023-06-07
Accepted
2023-06-07 17:40:19
Documents
4
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686174010.html 4  
1 FORM 4 wk-form4_1686174010.xml 4 3938
2 EX-24.1 acumen-section16limitedp.htm EX-24.1 3973
3 acumen-section16limitedp001.jpg GRAPHIC 195024
4 acumen-section16limitedp002.jpg GRAPHIC 37415
  Complete submission text file 0001576885-23-000032.txt   329556
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 231000057

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)